Loading Please Wait...

PicoPLEX DNA-seq Kit

PicoPLEXTM, the technology used by IVF clinics worldwide for pre-implantation genetic screening and diagnosis in detecting chromosomal aneuploidies and copy number variations, is now available for use on your Illumina NGS platform!

PicoPLEX DNA-seq kit streamlines library preparation; the entire process is performed in a single tube or well – reducing error and contamination, speeding time to results, and reducing costs.  PicoPLEX DNA-seq kit contains 48 reactions and includes everything necessary to convert 48 individual cells or DNA (6 pg to 60 pg) to NGS libraries, including dual barcodes. Barcoding oligonucleotides are provided in a single-use microwell plate.

  • Reduce ambiguity–highly reproducible CNV and aneuploidy detection
  • Reduce workflow–from a single cell to a sequencing-ready library in three steps
  • Reduce cost–a single kit contains everything needed to prepare a sequencing-ready library
  • Reduce contamination and error–library prep in a single tube or well, no transfers necessary
  • Reduce time to results–Illumina NGS  libraries prepared  in  less than 3 hours

ThruPLEX®-FD Prep Kit

The ThruPLEX-FD Prep Kit represents a breakthrough in library preparation that streamlines the Illumina Next Generation Sequencing protocol starting with fragmented DNA or cDNA.

ThruPlex employs patented technology based on stem loop adaptors and couples this with a high fidelity polymerase to deliver a highly efficient and user-friendly process. The entire reaction takes place in a single tube in less than 2 hours and eliminates purifications/clean-up steps. Efficiencies, sensitivities and reaction rates are all improved. Regardless of the NGS application– DNA-seq, RNA-seq, ChiP–seq-the ThruPLEX-FD Prep Kit provides consistent and reliable results.

Human Periodontal Disease Array Q1

Quantibody® Human Periodontal Disease Array 1 Kit.

Screen 20 key inflammatory and bone metabolic factors associated with active periodontal disease.

Targets include:
CRP, IFNg, IL-1a, IL-1b, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17, MIP-1a, MMP-9, MMP-13, OPG, OPN, Osteoactivin, RANK, TGFb1, TNFa

View the video below for how to perform Quantibody array experiment:

TransIT®-BrCa Transfection Reagent

TransIT®-BrCa Transfection Reagent is the first dedicated breast cancer cell line specific reagent available to researchers today. While it delivers efficiently to many breast cancer cell types, it also maintains low cellular toxicity resulting in reduced experimental biases.

  • Broad Spectrum DNA Delivery - Achieve high expression levels in breast cancer cell types including: MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, and T47D.
  • Formulated for Low Cellular Toxicity - Maintain cell density and reduce experimental biases due to toxicity.
  • Superior Transfection Efficiency - TransIT®-BrCa outperforms Lipofectamine® 2000, in multiple breast cancer cell lines.

A short video on youtube highlighting TransIT®-BrCa transfection reagent:

Signup for
    25 January 2017
    Manchester, UK, 24th January 2017 - Elucigene Diagnostics, developer and distributor of leading prenatal and human genetics diagnostics have today partnered with Genomax Technologies, to bring Elucigene leading brands such as CFEU2v1 and QST*R, to Singapore, Malaysia and Thailand.